Have a personal or library account? Click to login
Peculiarities of the detection and course of the pediatric extrapulmonary tuberculosis taking into account drug resistance Cover

Peculiarities of the detection and course of the pediatric extrapulmonary tuberculosis taking into account drug resistance

Open Access
|Oct 2022

References

  1. 1. World Health Organization. Global tuberculosis report 2016. Geneva: WHO; 2016. [https://apps.who.int/iris/bitstream/handle/10665/250441/9789241565394-eng.pdf?sequence=1&isAllowed=y.] (access: 3.01.2022)
  2. 2. World Health Organization. Global tuberculosis report 2021. Geneva: WHO; 2021. [https://www.who.int/publications/i/item/9789240037021.] (access:3.01.2022)
  3. 3. Analytical and statistical reference bookTuberculosis in Ukrainefor 2020. Public Health Center of the Ministry of Health of Ukraine. [https://www.phc.org.ua/sites/default/files/users/user90/TB_surveillance_statistical-information_2020_dovidnyk.pdf.]
  4. 4. Bielogortceva OI, Dotcenko YaI, Rekalova OM, Pobedionna GP, Sivachenko OE. Some features of the immune system in children with local forms of tuberculosis. J Clin Exp Med Res (Ukr). 2015;3(1):70-6.
  5. 5. Feshchenko YuI, Todoriko LD, Kuzhko MM, Humenyuk MI. Pathomorphosis of tuberculosis – the realities of the day and chemioresistance as a sign of it’s progression. Ukr pulmonol Zhurn (Ukr). 2018;2:6-10.10.31215/2306-4927-2018-100-2-6-10
  6. 6. Perez-Velez CM, Marais BJ. Tuberculosis in children. NEJM. 2012;367(4):348-61.10.1056/NEJMra1008049
  7. 7. Nejat S, Buxbaum C, Eriksson M, Pergert M, Bennet R. Pediatric tuberculosis in Stockholm: a mirror to the world. PIDJ. 2012;31(3): 224-7.10.1097/INF.0b013e31823d923c
  8. 8. Sousa GJB, Silva JCO, Queiroz TV, Bravo LG, Brito GCB, Pereira AS, et al. Clinical and epidemiological features of tuberculosis in children and adolescents. Rev Bras Enferm. 2019;72(5):1271-1278.10.1590/0034-7167-2018-0172
  9. 9. Musellim B, Erturan S, Sonmez DE, Ongen G. Comparison of extra-pulmonary and pulmonary tuberculosis cases: factors influencing the site of reactivation. Int J Tuberc Lung Dis. 2005;9:1220-3.
  10. 10. Belogortseva OI, Sukhanova LA, Shekhter IE, Dotcenko Ya.I, Kolisnyk NS, Kirilova TV, et al. Prevalence of multidrug-resistant tuberculosis in children in Ukraine in the context of the overall incidence of tuberculosis. Ukr Pulmonol J (Ukr). 2019;1: 15-20.
  11. 11. Sankalp Y, Gautam R. Primary extra-pulmonary multidrug resistant tuberculosis of the sternum without HIV Infection. JCDR. 2017;11(1):1-3.
  12. 12. Stosic MB, Sagic L, Simic D, Jovanovic V, Rakic V, Adzic Vukicevic T. Tuberculosis and associated risk factors among children and adolescent population in Serbia: 12 year’s retrospective study. J Infect Dev Ctries. 2021;15(6):818-25.10.3855/jidc.14451
  13. 13. Rapid Communication: Key changes to treatment of multidrug- and rifampicin-resistant tuberculosis (MDR/RR-TB)/WHO. Geneva: World Health Organization; 2019. [https://www.paho.org/en/node/69034.]
  14. 14. Management of multidrug-resistant tuberculosis in children: A FIELD GUIDE. Fourth Edition. SENTINEL; 2019. [http://sentinel-project.org/wp-content/uploads/2019/02/Updated_DRTB-Field-Guide-2019-V3.pdf.]
  15. 15. Mozammel MdH, Abdullah-Al-Maruf Md, Abdullah Al Baki, Motiur Rahman AZ. Pattern of childhood tuberculosis in the Outpatient department of a Tertiary level hospital in Dhaka city. IJID. 2020;5(2):23-8.10.11648/j.ijidt.20200502.11
  16. 16. Sakhelashvili M, Kostyk O, Sakhelashvili-Bil O, Piskur Z. Features of the resistant forms of a specific process among children and teenagers from the multidrug-resistant tuberculosis infection foci: clinical picture and diagnostics. Georgian Med News. 2021;11(320):70-6.
  17. 17. Kang W, Yu J, Du J, Yang S. The epidemiology of extrapulmonary tuberculosis in China: A large-scale multicenter observational study. PLOS ONE. 2020;15(8).
  18. 18. Klymnyuk SI, Hryshchuk LA, Vynnychuk MO, Boiko TV, Smachylo IV, Lykhatska GV, et al. Diagnostic chemoresistant mycobacterium tuberculosis in the Ternopil region of Ukraine. Wiad Lek. 2020;73(5):959-62.10.36740/WLek202005122
  19. 19. Lesnic E, Niguleanu A, Ustian A, Todoriko L. Impact of drug resistance on the tuberculosis treatment outcome. Actual Infectology. 2017;5(2):78-84.10.22141/2312-413x.5.2.2017.105319
  20. 20. Shokri M, Najafi R, Niromand J, Babazadeh A, Javanian M, Bayani M, et al. The frequency of risk factors for pulmonary tuberculosis in tuberculosis patients in Babol, Northern Iran, during 2008-2015. Curr Issues Pharm Med Sci. 2018;31(3):144-7.10.1515/cipms-2018-0028
  21. 21. Newton SM, Brent AJ, Anderson S, Whittaker E, Kampmann B. Pediatric tuberculosis. Lancet Infect Dis. 2008;8(8):498-510.10.1016/S1473-3099(08)70182-8
  22. 22. Soeters M, de Vries AM, Kimpen JLL, Donald PR, Schaaf HS. Clinical features and outcome in children admitted to a TB hospital in the Western Cape – the influence of HIV infection and drug resistance. S Afr Med J. 2005;95(8):602-6.
  23. 23. Political declaration of the high-level meeting of the UN General Assembly on the fight against tuberculosis. New York, United Nations General Assembly; 2018. [https://www.who.int/tb/unhlmonTBDeclaration.pdf] (access: 2.08.2019)
DOI: https://doi.org/10.2478/cipms-2022-0023 | Journal eISSN: 2300-6676 | Journal ISSN: 2084-980X
Language: English
Page range: 123 - 128
Submitted on: Jan 4, 2022
|
Accepted on: Sep 2, 2022
|
Published on: Oct 27, 2022
Published by: Sciendo
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2022 Zoriana Ivanovna Piskur, Lesya Pylypiv, Olga Shvets, Manana Sakhelashvili, Olga Kostyk, Olga Sakhelashvili-Bil, published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.